Twin Tree Management’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-28,300
Closed -$7M 1779
2022
Q2
$7M Buy
28,300
+11,600
+69% +$3.13M 0.01% 751
2022
Q1
$5.53M Buy
+16,700
New +$5.14M 0.01% 893
2019
Q3
Sell
-29,900
Closed -$7.79M 1584
2019
Q2
$7.79M Sell
29,900
-64,900
-68% -$17.2M 0.04% 349
2019
Q1
$27.1M Buy
94,800
+31,400
+50% +$10.4M 0.14% 130
2018
Q4
$20.6M Buy
+63,400
New +$22M 0.13% 162
2018
Q1
Sell
-39,200
Closed -$7.35M 1369
2017
Q4
$7.35M Sell
39,200
-8,000
-17% -$1.49M 0.05% 309
2017
Q3
$7.96M Buy
+47,200
New +$7.14M 0.06% 276
2017
Q1
Sell
-14,800
Closed -$1.67M 1335
2016
Q4
$1.67M Sell
14,800
-1,500
-9% -$174K 0.02% 670
2016
Q3
$2.1M Buy
+16,300
New +$1.95M 0.03% 492

Other funds holding ABMD

Twin Tree Management's ABMD Position: Q3 2022 in Review

Twin Tree Management sold out of Abiomed Inc (ABMD) in Q3 2022, closing a stake of 11,827 shares — an estimated $3.19M sold.

Twin Tree Management first reported a position in ABMD in Q4 2016 and held it in 11 quarters. The position peaked at $9.72M in Q1 2019. 517 funds tracked by Wall St. Rank hold ABMD as of Q3 2022.

  • Twin Tree Management reported no remaining Abiomed Inc position as of Q3 2022 after selling out during the quarter.
  • Twin Tree Management sold 11,827 Abiomed Inc shares in Q3 2022, an estimated $3.19M.
  • Twin Tree Management first reported a position in Abiomed Inc in Q4 2016 and held it in 11 quarters.
  • Twin Tree Management's Abiomed Inc position peaked at $9.72M in Q1 2019.
  • 517 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2022.

Based on Twin Tree Management's 13F filing for Q3 2022, filed 10 Nov 2022.